Trauma surgery patients often miss opportunities to engage in routine healthcare, including Hepatitis C (HCV) screening. We developed a HCV screening and linkage program to assess the incidence, prevalence, linkage to care rates, and HCV cure rates among this vulnerable population.
From August 2016 to March 2018, HCV screening was performed on patients evaluated at an urban Level I trauma center. Data were collected including HCV antibody status, HCV RNA status, sex, race, age, year of birth, and history of intravenous drug use (IVDU). Midway through the study (May 2017), a reflex HCV screening test was introduced, in which a HCV antibody positive sample would automatically undergo the HCV RNA test without an additional blood draw and/or return visit. Patients with a positive test result were linked to care or re-engaged in care by the navigator. Follow-up was performed to assess the cascade of care among patients who tested HCV RNA positive.
There were 2,953 patients eligible for HCV screening and 2,782 were screened (94.2%). There were 366 patients with HCV antibodies (13.2%) and 189 (6.8%) with detectable HCV RNA and 36 (1.3%) patients were newly diagnosed. Of the patients with a positive HCV antibody, 292 (79.8%) underwent a confirmatory HCV RNA test. Before the reflex test, there were 0.21 positive HCV RNA tests per day compared to 0.41 positive HCV RNA tests per day after the reflex test was introduced. Men comprised 148 (78.3%) of the chronic HCV patients. The average age was 47 (22-87). There were 70 (37%) Black, 65 (34.3%) White, and 42 (22.2%) Hispanic patients. There were 85 (44.9%) patients born between 1945-1965 and117 (61.9%) patients with a history of IVDU, but 28 (14.8%) were neither a baby boomer nor a person who injected drugs. Of the 189 patients with detectable viral loads, 142 (75.1%) were linked to care either by education or attending their first HCV medical appointment. Of these patients, 9 (4.8%) were cured of HCV.
The high rate of patients with chronic HCV (6.8%) in the trauma surgery service suggests that trauma surgery patients are at risk for HCV and should be routinely screened. Reflex HCV antibody to RNA testing increased the identification of patients living with chronic HCV. This program linked 75% of patients and cured 5% of HCV. The trauma surgery setting has significant potential to screen, diagnose, link to care and cure a vulnerable population that may not engage in routine medical care.